Nisa Investment Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.2K Sell
610
-39
-6% -$2.36K ﹤0.01% 1927
2026
Q1
$36K Sell
649
-314
-33% -$16.9K ﹤0.01% 1807
2025
Q4
$46.7K Sell
963
-87
-8% -$3.39K ﹤0.01% 1639
2025
Q3
$32.2K Hold
1,050
﹤0.01% 1786
2025
Q2
$23.3K Sell
1,050
-230
-18% -$4.81K ﹤0.01% 1865
2025
Q1
$23.8K Buy
1,280
+10
+0.8% +$167 ﹤0.01% 1809
2024
Q4
$16.8K Buy
1,270
+76
+6% +$1.84K ﹤0.01% 1988
2024
Q3
$40K Hold
1,194
﹤0.01% 1696
2024
Q2
$29.9K Buy
1,194
+54
+5% +$1.26K ﹤0.01% 1807
2024
Q1
$25.7K Hold
1,140
﹤0.01% 1810
2023
Q4
$24.4K Sell
1,140
-16
-1% -$276 ﹤0.01% 1821
2023
Q3
$20.8K Buy
1,156
+16
+1% +$305 ﹤0.01% 2005
2023
Q2
$23.2K Buy
1,140
+137
+14% +$2.78K ﹤0.01% 2051
2023
Q1
$22K Buy
1,003
+100
+11% +$2.43K ﹤0.01% 1973
2022
Q4
$28K Hold
903
﹤0.01% 1947
2022
Q3
$24K Buy
903
+23
+3% +$539 ﹤0.01% 2000
2022
Q2
$18K Hold
880
﹤0.01% 2068
2022
Q1
$22K Buy
+880
New +$26.6K ﹤0.01% 2032
2021
Q4
Sell
-980
Closed -$27K 2189
2021
Q3
$27K Hold
980
﹤0.01% 2034
2021
Q2
$25K Sell
980
-200
-17% -$4.79K ﹤0.01% 2091
2021
Q1
$25K Hold
1,180
﹤0.01% 2092
2020
Q4
$25K Buy
1,180
+150
+15% +$3.64K ﹤0.01% 2092
2020
Q3
$15K Hold
1,030
﹤0.01% 2072
2020
Q2
$23K Sell
1,030
-1,000
-49% -$18.3K ﹤0.01% 1748
2020
Q1
$29K Buy
2,030
+1,200
+145% +$18.2K ﹤0.01% 1640
2019
Q4
$13K Buy
830
+650
+361% +$15.4K ﹤0.01% 1777
2019
Q3
$6K Buy
180
+80
+80% +$3.81K ﹤0.01% 1868
2019
Q2
$6K Hold
100
﹤0.01% 1852
2019
Q1
$7K Hold
100
﹤0.01% 1844
2018
Q4
$6K Hold
100
﹤0.01% 1756
2018
Q3
$10K Buy
+100
New +$8.3K ﹤0.01% 1717

Other funds holding ANAB

Nisa Investment Advisors's ANAB Position: Q2 2026 in Review

Nisa Investment Advisors reduced its AnaptysBio (ANAB) stake by 6% in Q2 2026, selling an estimated $2.36K and leaving 610 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Nisa Investment Advisors first reported a position in ANAB in Q3 2018 and has held it in 31 quarters since. The position peaked at $46.7K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Nisa Investment Advisors held 610 shares of AnaptysBio worth $41.2K as of Q2 2026.
  • Nisa Investment Advisors sold 39 AnaptysBio shares in Q2 2026, an estimated $2.36K.
  • AnaptysBio made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1927 holding.
  • Nisa Investment Advisors first reported a position in AnaptysBio in Q3 2018 and has held it in 31 quarters since.
  • Nisa Investment Advisors's AnaptysBio position peaked at $46.7K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.